title: [Intralymphatic immunotherapy: An effective and safe alternative route for canine atopic dermatitis].
abstract: Allergen-specific immunotherapy (ASIT) is the only etiologic treatment of atopic dermatitis in dogs. In humans it has been shown that intralymphatic immunotherapy (ILIT) enhanced efficacy and patient compliance and reduced treatment time from 3 years to 8 weeks. As only safety data have been published yet, the aim of this study was to evaluate the clinical efficacy of ILIT in dogs. 20 atopic dogs underwent ILIT with alum-precipitated allergens administered every 4 weeks for 3 to 7 times in the popliteal lymph node. Pruritus (Hill score), CADESI (canine atopic dermatitis severety index), concurrent medications and adverse reactions were recorded initially and every 4 weeks for a total period of 24 weeks. The observed clinical response was good in 12/20 (60%) patients and improvement could be seen in some dogs already after 4 weeks. The median number of injections was 5.6. All dogs tolerated the procedure well and no adverse effects were recognized during or after ILIT. Therefore ILIT should be regarded as a safe alternative to subucaneous ASIT, enabling a faster clinical improvement with the same response rate.
authors.affiliation: Klinik für Kleintiermedizin, Abteilung für Dermatologie, Vetsuisse-Fakultät, Universität Zürich.
authors.forename: N
authors.initials: N
authors.lastname: Fischer
authors.affiliation: Klinik für Kleintiermedizin, Abteilung für Dermatologie, Vetsuisse-Fakultät, Universität Zürich.
authors.forename: A
authors.initials: A
authors.lastname: Rostaher
authors.affiliation: Klinik für Kleintiermedizin, Abteilung für Dermatologie, Vetsuisse-Fakultät, Universität Zürich.
authors.forename: C
authors.initials: C
authors.lastname: Favrot
mesh_terms: D000485:Allergens / Q000008:administration & dosage* / Q000276:immunology; D000818:Animals; D003876:Dermatitis, Atopic / Q000628:therapy / Q000662:veterinary*; D004285:Dogs; D005260:Female; D007167:Immunotherapy / Q000592:standards / Q000662:veterinary*; D007272:Injections, Intralymphatic / Q000662:veterinary; D008297:Male; D016896:Treatment Outcome
chemical_list: D000485:Allergens
keywords: Allergenspezifische Immuntherapie,
  intralymphatische Immuntherapie; Allergie; allergenspecific Immunotherapy; allergy; canine atopic dermatitis; canine atopische
  Dermatitis; intralymphatic
  immunotherapy